Preventing stalling to improve CAR-T cells' efficacy against tumors
Chimeric antigen receptor (CAR)-T cells are a promising cancer therapy that are made from the patient's own T cells, which are reprogrammed to fight their cancer. One of the limitations of CAR-T cell therapy is the ability ...
Jun 13, 2025
0
24
